WASHINGTON DC (December 16, 2019) — Finance Committee Chairman Charles "Chuck" Grassley (R-IA) and Senate Appropriations Committee Vice Chairman Patrick Leahy (D-VT) Monday hailed the inclusion of their legislation to combat anticompetitive practices used by some brand-name pharmaceutical and biologic companies to block entry of lower-cost generic drugs in the domestic appropriations package filed today in the House.








